{"id":198418,"date":"2024-10-19T12:37:51","date_gmt":"2024-10-19T12:37:51","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-14161-2009-ra-2014\/"},"modified":"2024-10-25T05:10:54","modified_gmt":"2024-10-25T05:10:54","slug":"aami-14161-2009-ra-2014","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-14161-2009-ra-2014\/","title":{"rendered":"AAMI 14161 2009 RA 2014"},"content":{"rendered":"
Provides guidance for the selection, use, and interpretation of results from the application of biological indicators in the development, validation, and routine monitoring of sterilization processes.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 14161:2009\/(R)2014, Sterilization of health care products \u2014 Biological indicators \u2014Guidance for the selection, use and interpretation of results <\/td>\n<\/tr>\n | ||||||
2<\/td>\n | Objectives and uses of AAMI standards and recommended practices <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Committee Representation <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | Background of ANSI\/AAMI adoption of ISO 14161:2009 <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 1 Scope 2 Normative references <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 4 General <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 5 Characteristics of biological indicators 5.1 General <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 5.2 Test organism suspension for direct inoculation of products <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 5.3 Inoculated carriers 5.4 Self-contained biological indicators <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 5.5 Other biological indicators 6 Selection of supplier 6.1 General <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 6.2 Documentation 6.2.1 General 6.2.2 Manufacturer audit <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 7 Biological indicators in process development 7.1 General <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | 7.2 Overkill approach <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 7.3 Combined biological indicator and bioburden method <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 7.4 Bioburden method 8 Biological indicators in sterilization validation 8.1 General 8.2 Placement and handling of biological indicators <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 8.3 Sterilizer qualification 8.4 Performance qualification 8.5 Review and approval of validation 8.6 Requalification <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 9 Biological indicators in routine monitoring 9.1 General 9.2 Placement and handling of biological indicators <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 9.3 Process challenge device (PCD) 10 Results 10.1 General 10.2 Interpretation of results <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | 11 Application of biological indicator standards 11.1 General assessment of biological indicator performance by the user 11.2 Nominal population of test organism <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | 11.3 Resistance determination 11.3.1 General <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | 11.3.2 Survivor curve method 11.3.3 Fraction-negative method <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | 11.3.4 Survival-kill response characteristics 11.4 z value determination 11.4.1 General <\/td>\n<\/tr>\n | ||||||
37<\/td>\n | 11.4.2 Graphically plotting the z value 11.4.3 Mathematically calculating the z value <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | 11.4.4 Correlation coefficient, r, for the z value <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | 11.5 F(T,\u00a0z) equivalent sterilization value determination 11.6 Establishing spore-log-reduction (SLR) <\/td>\n<\/tr>\n | ||||||
40<\/td>\n | 11.7 Sterility assurance level (SAL) calculation 11.8 Test equipment 12 Culture conditions 12.1 General <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | 12.2 Incubation temperature 12.3 Incubation period 12.4 Choice of growth medium <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | 13 Third-party requirements 13.1 General <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | 13.2 Minimum requirements for replicates and total number of biological indicators 13.3 Test equipment <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | 14 Personnel training 15 Storage and handling 16 Disposal of biological indicators <\/td>\n<\/tr>\n | ||||||
46<\/td>\n | Annex A Microbiological inactivation kinetics and enumeration techniques <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | Annex B Process challenge devices B.1 General B.2 Helices B.3 Standard test packs B.4 User’s process challenge devices <\/td>\n<\/tr>\n | ||||||
53<\/td>\n | B.5 Biological test packs <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | Annex C Formulae for fraction negative methods for D value calculations (adapted from ISO 11138-1:2006, Annex D) C.1 General C.2 Materials <\/td>\n<\/tr>\n | ||||||
55<\/td>\n | C.3 Methods C.3.1 Holcomb-Spearman-Karber Procedure (HSKP) C.3.1.1 Introduction C.3.1.2 Calculations using the HSKP <\/td>\n<\/tr>\n | ||||||
58<\/td>\n | C.3.1.3 Example calculation of the Holcomb-Spearman-Karber Procedure (HSKP) <\/td>\n<\/tr>\n | ||||||
61<\/td>\n | C.3.2 Limited Holcomb-Spearman-Karber Procedure (LHSKP) C.3.2.1 Calculations using the LHSKP <\/td>\n<\/tr>\n | ||||||
63<\/td>\n | C.3.2.2 Example calculations of the Limited Holcomb-Spearman-Karber Procedure (LHSKP) <\/td>\n<\/tr>\n | ||||||
65<\/td>\n | C.3.3 Stumbo-Murphy-Cochran Procedure (SMCP) C.3.3.1 Introduction C.3.3.2 Calculations using the SMCP <\/td>\n<\/tr>\n | ||||||
66<\/td>\n | C.3.3.3 Example calculations of the Stumbo-Murphy-Cochran Procedure (SMCP) <\/td>\n<\/tr>\n | ||||||
70<\/td>\n | Annex D Examples of documentation for biological indicators prepared by the user D.1 General D.1.1 Sources of microorganisms D.1.2 Documentation <\/td>\n<\/tr>\n | ||||||
71<\/td>\n | D.2 Commercially available suspension D.3 Suspension from a commercially available strain <\/td>\n<\/tr>\n | ||||||
72<\/td>\n | D.4 Suspension from in-house isolates D.5 Inoculated carriers D.5.1 General D.5.2 Documentation of fluid carrier materials <\/td>\n<\/tr>\n | ||||||
73<\/td>\n | D.5.3 Documentation of solid carrier materials D.5.4 Documentation of inoculated carriers used for D value determinations <\/td>\n<\/tr>\n | ||||||
75<\/td>\n | Annex E Calculation of z value (adapted from ISO 11138-3:2006, Annex B) <\/td>\n<\/tr>\n | ||||||
78<\/td>\n | Annex F D value determination by survivor curve method (adapted from ISO 11138-1:2006, Annex C) F.1 General F.2 Materials F.3 Procedure <\/td>\n<\/tr>\n | ||||||
82<\/td>\n | Annex G Survival-kill response characteristics (adapted from ISO 11138-1:2006, Annex E) G.1 General G.2 Materials G.3 Method <\/td>\n<\/tr>\n | ||||||
83<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 14161-2009\/(R)2014 – Sterilization of health care products – Biological indicators – Guidance for the selection, use and interpretation of results<\/b><\/p>\n |